NTI
Click for more information
1.52% 6.5¢ neurotech international limited

Ann: Phase I/II PANDAS/PANS Clinical Trial Meets Primary Endpoint, page-7

  1. praying
    823 Posts.
    lightbulb Created with Sketch. 74
    clock Created with Sketch.
    06/10/23
    11:16
    Post #: 70205591
    They have sway in the marketplace as well as very good PR . Great way to showcase any company. If you don't subscribe I recommend it. Great to trade off if not in for the long run .
    NTI Price at posting: 6.4¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
right-arrow Created with Sketch.
NEWS Dale Gillham's weekly wrap: picking resilient stocks in a volatile global market
right-arrow Created with Sketch.
TG6 TG Metals reports high grade lithium hits approaching 3% at Jaegermeister
right-arrow Created with Sketch.
NEWS Bitcoin: Current State of Play & Where to Next | Swyftx
right-arrow Created with Sketch.
RLT South Africa-based Renergen brings liquid helium facility online
right-arrow Created with Sketch.
QBE QBE records share price plunge despite doubling profits in the first half of 2024
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.5¢ 		Change
-0.001(1.52%) 		Mkt cap ! $66.13M
Open High Low Value Volume
6.8¢ 6.8¢ 6.5¢ $60.48K 916.3K

Buyers (Bids)

No. Vol. Price($)
2 152322 6.6¢
 

Sellers (Offers)

Price($) Vol. No.
6.8¢ 59984 2
View Market Depth
Last trade - 15.59pm 09/08/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.